Basilea Pharmaceutica

This study tests a new medicine called fosmanogepix for adults with serious mold infections that are hard to treat. About 234 people will join, receiving either the new drug or standard care. The main goal is to see if the drug lowers the chance of death within 42 days.

This study tests a new medicine called fosmanogepix for treating life-threatening Candida infections in the blood or body. About 450 adults will receive either the new drug or standard treatment. The goal is to see if fosmanogepix works as well as current options, with treatment …

This early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam etzadroxil) in about 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Results will help decide if further studies are po…

This study is the first time BAL2420 is being tested in humans. It aims to check the safety and how the body processes the drug in 136 healthy adults. Participants receive either the drug or a placebo, and researchers monitor for side effects. The goal is to gather essential safe…